115 results
6-K
EX-99.1
ALVO
Alvotech
1 Mar 24
Alvotech Appoints Interim Chief Quality Officer
12:16pm
and future litigation regarding Alvotech’s products and product candidates; (14) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review … -19 pandemic on the Alvotech’s business, financial position, strategy and anticipated milestones; (16) future liquidity and financing needs, which may
6-K
EX-99.1
ALVO
Alvotech
15 Feb 24
Current report (foreign)
4:00pm
candidates; (14) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review timelines, including its ability to complete timely … conditions, war in Ukraine and global geopolitical tension, and the ongoing and evolving COVID-19 pandemic on the Alvotech’s business, financial
6-K
EX-99.1
ALVO
Alvotech
29 Jan 24
Current report (foreign)
7:00am
and product candidates; (18) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review timelines, including its ability to complete … market conditions, war in Ukraine and global geopolitical tension, and the ongoing and evolving COVID-19 pandemic on the Company’s business, financial
6-K
EX-99.1
ALVO
Alvotech
10 Jan 24
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
7:00am
Alvotech’s products and product candidates; (16) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review timelines, including its ability
6-K
EX-99.1
8ngx6847vbhq
3 Jan 24
Current report (foreign)
2:28pm
6-K/A
EX-99.1
e5y4y4k8t5018
30 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
9:19am
6-K
EX-99.1
dv3hgq2ouwwu
29 Nov 23
Current report (foreign)
7:00am
6-K
EX-99.1
ufb1uvlk
29 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
7:00am
6-K
EX-99.1
m16vz0s61gp1 g8
14 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
u4o553y8h mi1ljf
13 Nov 23
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
6:15am
F-3
onkysj8a wt
20 Oct 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
wjzw3vhhm 4clir
12 Oct 23
Alvotech Provides Update on Status of U.S. Biologics License Application for AVT04
9:00am
6-K
EX-99.1
jsyyq
3 Oct 23
Current report (foreign)
8:51am
6-K
EX-99.1
hdausy
25 Sep 23
Current report (foreign)
4:30pm
6-K
EX-99.1
37xjpeopzpat 3i44hsw
21 Sep 23
Current report (foreign)
7:59am
6-K
EX-99.1
xllgaz6q
5 Sep 23
Alvotech Announces Changes to the Leadership Team
4:51pm
6-K
EX-99.2
4vyeio93
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.8
r41qa3ias cj3yl7
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.1
je11boblw9v9cidrqt1j
1 Aug 23
Alvotech Completes $100 Million
8:00am